Sign in

CIK 0001709941 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

BioAge Labs, Inc.

Sign in to watch
Ticker
BIOA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
474721157
Phone
510-806-1445
Business address
5885 HOLLIS STREET, SUITE 370, EMERYVILLE, CA, 94608
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-30 Barton Shane Principal Accounting Officer Sale 10b5-1 −20,216 $25.19 $509K 0
2026-06-29 Barton Shane Principal Accounting Officer Sale 10b5-1 −42,350 $25.21 $1.1M 0
2026-04-01 RUBIN PAUL D Chief Medical Officer Sale 10b5-1 −8,820 $17.81 $157K 0
2026-03-02 RUBIN PAUL D Chief Medical Officer Sale 10b5-1 −7,433 $20.30 $151K 0
2026-02-02 RUBIN PAUL D Chief Medical Officer Sale 10b5-1 −7,433 $18.75 $139K 0
2026-01-13 Fortney Kristen Chief Executive Officer Sale 10b5-1 −233,107 $18.12 $4.2M 976,949
2026-01-13 GOLDSTEIN DOV A MD Chief Financial Officer Sale 10b5-1 −8,974 $18.43 $165K 40,434
2026-01-13 GOLDSTEIN DOV A MD Chief Financial Officer Sale 10b5-1 −4,440 $19.45 $86K 35,994
2026-01-13 GOLDSTEIN DOV A MD Chief Financial Officer Sale 10b5-1 −11,663 $20.54 $240K 24,331
2026-01-13 GOLDSTEIN DOV A MD Chief Financial Officer Sale 10b5-1 −1,923 $21.08 $41K 22,408
2026-01-02 RUBIN PAUL D Chief Medical Officer Sale 10b5-1 −7,433 $12.85 $95K 0
2025-12-09 RUBIN PAUL D Chief Medical Officer Sale 10b5-1 −18,000 $12.00 $216K 0
2025-12-04 RUBIN PAUL D Chief Medical Officer Sale 10b5-1 −68,897 $10.19 $702K 0

Page 1 of 1 · 13 trades